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ABSTRACT
Objective: The objective of this work was to carry out studies in the field of development of a hydroalcoholic extract from the liquorice root that has a high level of antimicrobial activity.
Methods: For the antibacterial study of extracts, we have used the agar well diffusion method. In our research, we have utilized six test-strain microorganisms: Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Proteus vulgaris ATCC 4636, Pseudomonas aeruginosa ATCC 27853, 
Candida albicans ATCC 885/653, and Bacillus subtilis ATCC 6633. Authors have applied vector theory for antimicrobial activity comparison of liquorice root extracts.
Results: Phytochemical composition and antimicrobial activity of hydroalcoholic extracts from the liquorice root with the use of different concentrations of ethanol have been studied. The optimal range of ethanol concentration of 65±15% v/v has been found. The dependency between the integral index of antimicrobial activity of the extract and concentration of glycyram and licuroside has been found. The minimal concentration of glycyram and licuroside in the extract has been calculated for an exhibition of the target level of extract’s antimicrobial activity, which is 1.0 and 0.11% w/v, respectively.
Conclusion: It has been found that the concentration of licuroside has greater influence on the integral index of extract’s antimicrobial activity in comparison with that one of glycyram. A highly effective technology for obtaining an extract with target phytochemical parameters has been suggested.
Keywords: Liquorice root, Antimicrobial activity, Extracts, Glycyram, Licuroside, Correlation.
INTRODUCTIONDevelopment and practical application of antimicrobial drugs for local wound treatment for infectious injuries of skin and mucous membrane for human/animals is a rather urgent issue [1].It is not uncommon that for successful treatment we need drugs with several simultaneous pharmacological effects, which is impossible at present state of science and technology relating to one agent and, therefore, we need to add additional active agents with other pharmacological effects into the drug formulation.A good alternative to mono- or combination therapy for local treatment of infectious injuries of skin and mucous membrane is to use plant extracts that may be used for development of different drug dosage forms (tablets, ointments, aerosols, solutions, sprays, etc.).These drugs have polyfunctional properties as a result of different constituents present in their composition that has different biological effects. Many of them are accepted by the official medicine and described in National Pharmacopoeias of different countries as plant raw materials, tinctures, and extracts. However, these dosage forms still have some unsolved problems.Despite a long-time use of tinctures and extracts in many countries, scientific grounding for choice of extractant type is still an unsolved issue in medicine and pharmacy.
The liquorice root has a long tradition of medicinal use for the treatment of different types of diseases [2,3]. Biologically active substances from the liquorice root exhibit the following effects: Antioxidant, expectorative, anti-inflammatory, anti-allergic, healing, spasmolytic, antiviral, antibacterial, and antiproliferative, etc., [4-8]. The dominant biologically active substances from Glycyrrhizae radix are glycyrrhizic acid (triterpene saponosides), chalcones (licurosid), and flavonoids (liquiritin, and liquiritigenin) [9-12]. Therefore, the development of drugs from the liquorice root with antimicrobial activity for local used is an actual task.The aim of this work was to carry out complex studies in the field of obtaining of a hydroalcoholic extract with antimicrobial activity from liquorice root for local use both, in medical and veterinary practice.
METHODS
Plant materialFor studies, we used Glycyrrhiza radices (liquorice roots) by “Krasnogorskleksredstva” company, Krasnogorsk, the Russian Federation, serial No 30417, best before 05/2018. For extraction, we used plant raw material with particle size of 0.1–0.5 mm.
Solvents and standardsAs an extractant, we used water solutions of ethanol (22, 41, 50, 71, 82, 96±1% v/v). Ethanol was of pharmaceutical grade (Russia).
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Qualitative and quantitative analyses of biologically active compounds were carried out with reference substances of licuroside and monoammonium glycyrrhizinate (glycyram) (the State Pharmacopoeia of Ukraine) and according to UV-spectra and retention times of these compounds in the high performance liquid chromatography (HPLC) profile.
Preparation of extractsExtracts for analysis were obtained as follows: Transfer 4 g of the grinded plant raw material (accurately weighed) into a flask, add 20.0 ml of the solvent (accurately weighed) and macerate for 24 h at 
25±1°С.Then, the extract was decanted and centrifuged at 3000 rpm for 30 min; it was used for antimicrobial activity studies and analyzed by a reversed-phase HPLC.
 HPLC analysisThe chromatographic studies were carried out with a chromatograph of Agilent 1200 infinity series by Agilent Technologies, the USA. The chromatographic process was carried out under the following conditions: Mobile phase (A): 1% water solution of formic acid, second mobile phase (B): 96% v/v ethanol in linear gradient elution regime; chromatographic column: Supelco ascentis express C18 100 mm×4.6 mm with particle size 2.7 μm; mobile phase velocity: 0.5 ml/min; temperature of the chromatographic column: +35оС; and 
sample volume: 1 μl [13].
Suitability and validation parameters of the chromatographic 
methodThe main parameters of the validation method of analysis and suitability of HPLC system for determination of licuroside and glycyram are presented in Table 1.
Method of dry residue determinationDry residue in the extract was determined by a gravimetric method in accordance with general pharmacopeia monograph extracts GPhA.1.4.1.0021.15 of the Russian State Pharmacopoeia [15].
Antimicrobial assayFor antimicrobial activity study, we used an agar well diffusion method. For the study, we used six test-strain microorganisms: Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Proteus vulgaris ATCC 4636, Pseudomonas aeruginosa ATCC 27853, Candida albicans ATCC 885/653, and Bacillus subtilis ATCC 6633.The microbial burden was 107 CFU/ml for upper-layer of the medium. The volume of test extracts was 0.275±0.025 ml. The diameter of wells was 10 mm, and the total width of agar layers was 4.0±0.5 mm. Mueller-Hinton agar was used for bacteria. Sabouraud agar was used for C. albicans. Determination of the antimicrobial activity of extracts was carried out on two layers of solid medium in Petri dishes. 0.05% 
water solution of chlorhexidine gluconate and 0.5% w/v glycyram solution in ethanol 70% v/v were used as positive controls, and ethanol solutions were used as negative controls.
TheoryFor ease of use and functional description of the antimicrobial activity of extracts from any physical or chemical parameters, we used vector theory, which makes it possible to describe values of extract’s antimicrobial activity using several test-strains as one integral vector in n-dimension space. This vector is characterized by the length that describes the “strength” of extract’s antimicrobial activity, A; with a slope angle that describes the “spectrum” of extract’s action in test-strains of the microorganisms studied, r2; with a distance between the end point of vectors (extract and a standard drug) that describes the “degree of similarity” of extract’s antimicrobial properties and standard 
antimicrobial drug, ΔXSt.Calculation of the integral index of extract’s antimicrobial activity, A, was carried out by the following formula:
 
2 21 125 25n na D a DA ⋅ ⋅   = + ⋅⋅ ⋅ +        (1)where A is an integral index of antimicrobial activity for the extract; it is a gradational and dimensionless value in case of growth inhibition zone diameter use, efficiency index range: 1.0–1.5, the extract has weak antimicrobial activity; 1.5–2.5, the extract has medium antimicrobial activity; <2.5, the extract has strong antimicrobial activity. We calculated these values by putting respective limits of growth inhibition zone diameter (10, 15, and 25 mm) into formula (1); а1., аn are relative normalized weight importance coefficients of strains, species, and types of microorganisms in the diseases against which we used the extract. It is the proportion of people affected by this microorganism. The coefficient range is from 0 to 1. In our calculations, it is taken as 1; D1. Dn are mean values of growth inhibition zone diameters of test microorganisms, in mm. For example, D1 is the mean value of growth inhibition zone diameter of C. albicans ATCC 885/653, and Dn is the mean value of growth inhibition zone diameter of B. subtilis ATCC 6633; δD1. δDn are errors of growth inhibition zone diameters of test microorganisms, in mm; 25 is normalized value, which makes it possible to transform values of growth inhibition zone diameters of test microorganisms to dimensionless values of the integral index of antimicrobial activity (А) of the extracts.
The correlation coefficient (cosγ = r) between vectors and distance 
between the end point of vectors (ΔXSt) was calculated by the following formulas:
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Table 1: Main parameters of the validation method of analysis and suitability of HPLC system for determination of licuroside and 
glycyram
Parameter Pharmacopeia limitation [14] Compound
Licuroside GlycyramRetention time (tR), min – 21.7±0.3 35.3±0.3 and 35.9±0.3Asymmetry coefficient (T) ≤2.0 0.8 0.68 and 0.72Separation coefficient (Rs) ≥1.5 2.31 1.65 and 1.50Theoretical plates number (N) ≥1000 169,803 699,649 and 888,042RSD of peak’s area, % ≤2.0 1.7 1.9 and 1.9LOD, g/ml – 2.0·10–5 8.9·10–5LOQ, g/ml – 6.1·10–5 2.7·10–4Determination coefficient, r2 ≥0.99 0.9999 0.9997Calibration linear equation, C (g/ml)=f (S (mAU·s) – C=(2.29±0.04)·10–7·S C=(1.77±0.06)·10–6·SHPLC: High performance liquid chromatography
405
Asian J Pharm Clin Res, Vol 12, Issue 1, 2019, 403-407
 Boyko et al. 
 
22
1 1 1
25 25
   ⋅ −⋅ −
Δ = + ⋅ ⋅ ⋅+   
   
StSt
n n n
XSt
a ( D D )a ( D D )
 (3)where аiX,… аiSt are relative normalized weight importance coefficients of test-strains for the test extract - Х and “standard” - St. In our calculations, it is taken as 1; DiX … DiSt are mean values of growth inhibition zone diameters of test microorganisms, for the test extract - X and for “standard” - St, in mm.In our research, we used a virtual vector as “standard” with some conventional coordinates for all test-strain, for example, DiSt=25.0 mm (for growth inhibition zone diameters of test microorganisms). This value was chosen because it is a breakpoint between such categories of microorganism sensitivity to antimicrobials as intermediate and sensitive.
Regression analysisFor the construction of the regression model of dependency of the integral index of extract’s antimicrobial activity from the glycyram and licuroside concentration, we used table curve 3D v4.0 program.
RESULTS AND DISCUSSIONIn the first series of experiments, phytochemical studies of extracts by HPLC and gravimetric methods have been carried out. The results of the quantitative analysis of licuroside, glycyram, and dry residue are presented in Table 2.
As it can be seen from the data of Table 2, maximum concentration of licuroside is observed in the extract based on ethanol 71% v/v, and for glycyram, in the extract based on ethanol 41% v/v, moreover, in the extract based on ethanol 96% v/v, its concentration was 173-fold less than in the extract based on ethanol 41 % v/v. These data agree with our previous studies [13].In the second series of experiments, studies of the antimicrobial activity of extracts by in vitro agar diffusion methods, the variant of “wells,” has been carried out. The results of the antimicrobial activity of extracts and reference drugs are presented in Table 3.As it can be seen from Table 3, all extracts demonstrate the high level of antimicrobial activity, but its maximum value was detected for the extract with ethanol 71 % v/v. Antimicrobial activity of this extract is almost similar to 0.05% chlorhexidine gluconate solution.For the possibility of comparison of the integral parameter of drugs’ antimicrobial activity between each other, we used vector algebra theory. In this connection, the results related to calculations of some important parameters using formulas (1)-(3) are presented in Table 4.As it can be seen from Table 4, the integral index of antimicrobial activity 
of the extract based on ethanol 71 % v/v A=2.08 has the equal value 
to the reference drug chlorhexidine gluconate A=2.07, but its vector is 
closely adjacent to the virtual drug in terms of parameter ΔASt=0.44 then 
the vector of the reference drug ΔASt=0.51. This can be explained by the fact that extract’s antimicrobial activity has less variation among the 
Table 2: Concentration of licuroside, glycyram, and dry residue in the extracts obtained from ethanol‑water solutions with different 
concentrations
Compound (λ, nm) Retention time, min* Compound concentration, % w/v
Ethanol, % v/v
22 41 50 71 82 961.  Licuroside concentration, % w/v (360.4 nm) 21.7±0.3 0.098±0.003 0.108±0.003 0.133±0.004 0.170±0.005 0.149±0.005 0.067±0.0022.  Glycyram concentration, % w/v (258.4 nm) 35.3±0.3 and 35.9±0.3 1.46±0.04 1.53±0.05 1.55±0.08 1.45±0.04 1.02±0.03 0.0088±0.00033. Dry residue, % w/v - 6.6±0.2 6.4±0.2 6.2±0.2 6.1±0.2 4.0±0.2 1.62±0.08
* The mean value and its confidence interval (mean±SEM) are calculated with repeat counts n=3 and significance level р=0.95. SEM: Standard error of the mean
Table 3: Antimicrobial activity of extracts from liquorice roots
No. Test‑strain microorganism Growth inhibition zone diameters of test microorganisms, in mm*
Ethanol concentration, % v/v Ch
Gl
** NC***
22 41 71 961. Staphylococcus aureus ATCC 25923 20.3±1.4 20.0±1.4 24.3±1.4 20.7±1.4 24 3 1 4
16 0 1 4
. .
. .
±
±
Growth
2. Escherichia coli ATCC 25922 21.0±1.4 20.3±1.4 22.3±1.4 18.7±1.4 2 7 14
14 7 14
0. .
. .
±
±
Growth
3. Pseudomonas aeruginosa ATCC 27853 18.3±1.4 19.0±1.4 20.3±1.4 20.3±1.4 17 14
14 14
. .
. .
0
0
±
±
Growth
4. Proteus vulgaris ATCC 4636 16.7±1.4 17.7±1.4 19.7±1.4 18.0±1.4 16 3 14
137 14
. .
. .
±
±
Growth
5. Bacillus subtilis ATCC 6633 22.7±1.4 23.3±1.4 22.7±1.4 22.3±1.4 227 14
16 7 14
. .
. .
±
±
Growth
6. Candida albicans ATCC 885/653 14.7±1.4 16.7±1.4 19.3±1.4 19.3±1.4 24 3 14
133 14
. .
. .
±
±
Growth
*Repeat counts n=3, significance level р=0.95; **Ch is 0.05% w/v chlorhexidine gluconate in water solution and Gl is 0.5% w/v glycyram solution in ethanol 71% v/v; ***C is negative control are ethanol solutions from 22 to 96% v/v
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test strains of microorganisms than the reference drug. From the data in Table 4, we can also see that the square correlation coefficient (r²) for all tested extracts and reference drugs have a high value of r²=0.99, this value demonstrates that extracts and drugs inhibit the growth of all test strains of microorganisms.At the next stage of our study, we carried out analysis of data and chose the type of correlation model for dependency between the integral index of extract’s antimicrobial activity and concentration of glycyram and licuroside. This stage was carried out with the use of table curve 3D v4.0 program.From mathematical equations proposed by the program, we chose only one equation that in our opinion was the most adequate for an explanation of the dependency of the integral index of extract’s antimicrobial activity and concentration of dominant components in the extract (glycyram and licuroside).The equation found is presented below:
 A=a+b lnCG+d lnCL (4)Where A is an integral index of extract’s antimicrobial activity; a is a constant that equals 4.22±0.2; b is a constant that equals – (minus) 0.041±0.004; CG is glycyram concentration, g/ml; d is a constant that equals 0.36±0.03; CL is licuroside concentration, g/ml.Determination coefficient of this equation is r²=0.99; moreover, all constants in the equation are significant and have the confidence interval of variation, not more than 10%.
Analysis of Equation (4) demonstrates that the coefficient at logarithm of licuroside concentration is greater than the coefficient at logarithm of glycyram concentration (0.36> 0.041), which indicates to the dominant influence of licuroside concentration in the extract on the integral index of antimicrobial activity.Moreover, the minus sign at the coefficient related to logarithm of glycyram concentration indicates to the fact that higher concentration of this substance in the extract leads to decrease of the integral index of antimicrobial activity that is an unexpected fact because as it can be seen from the data of Tables 3 and 4, this compound possesses antimicrobial activity.Then, using the regression equation obtained and addition data on phytochemical composition of extracts obtained with other ethanol concentrations (Table 2), we found the minimal values of glycyram and licuroside concentration, 1.0% w/v and 0.11% w/v, respectively, for exhibition of the integral index of extracts of antimicrobial activity with 
a target level of А=2.00±0.06.Thus, for development of production technology for obtaining a hydroalcoholic extract from the liquorice root with maximum antimicrobial activity level, we should use ethanol with concentration 65±15% v/v. Therein, for standardization of the extract, we should take into account concentrations of both licuroside and glycyram.At the final stage of our work, we carried out technological studies on obtaining of the extract with target concentration values of glycyram and licuroside by the filtration method of extraction.
Table 4: Integral antimicrobial parameters of extracts from liquorice roots
No. Parameter* Ethanol concentration, % v/v Ch** Gl**
22 41 71 961. Integral index of antimicrobial activity of extract, А±δА 1.88±0.06 1.92±0.06 2.08±0.06 1.95±0.06 2.07±0.06 1.45±0.062. Square correlation coefficient, r² 0.98 0.99 0.99 0.99 0.98 0.993. Distance from optimal zone, ΔASt 0.65 0.58 0.44 0.52 0.51 1.01
*Statistical calculations are carried out with repeat counts n=3 and significance level р=0.95; **Ch is 0.05% w/v chlorhexidine gluconate in water solution and Gl is 0.5% w/v glycyram solution in ethanol 71% v/v
Fig. 1: Diagram of dependency between the concentration of biologically active substances and the time
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Fig. 1 presents a diagram of dependency between the concentration of biologically active substances and the time of extract drainage at 1:1 ratio of volume extract/weight of plant raw material.As it can be seen from the data in Fig. 1, critical concentrations of glycyram (0.018 g/ml) and licuroside (0.0012 g/ml) in the extract are observed at the third drainage volume. Thus, from the technological point of view, it is more reasonable to obtain the extract with the 
composition determined at 25°С, plant raw material/extract ratio 1:3 (w/v), and extraction time 100 min.In accordance with the mathematical model, the integral index of extract’s antimicrobial activity for these concentrations of licurosid 
and glycyram should be equal to А=1.97, which is within the suggested range.These results form the background for the development of a rational technology for obtaining the extract from the liquorice root with maximum antimicrobial activity, as well as for analytical control of its quality.
CONCLUSIONPhytochemical and microbiological analyses of extracts from the liquorice root obtained with the use of different concentrations of ethanol have been carried out. Regression analysis of experimental data has been performed. An empirical dependency between the integral index of extract’s antimicrobial activity and glycyram and licuroside concentrations has been found. Minimal licuroside and glycyram concentrations in the extract for an exhibition of its target level of antimicrobial activity have been calculated. Using a filtration method of extraction, we obtained the extract that satisfies minimal phytochemical requirements related to glycyram and licuroside content.
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